MedTrace Logo

Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis

NCT00245440 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2007-10-31

No results posted yet for this study

Summary

The purpose of this study is to measure the speed of microbial eradication due to azithromycin or telithromycin in acute maxillary sinusitis (AMS).

Conditions

  • Maxillary Sinusitis

Interventions

DRUG

Azithromycin

250 mg tablets; 2 tablets once daily (500 mg) for 3 days

DRUG

Telithromycin

400 mg tablets; 2 tablets once daily (800 mg) for 5 days

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • CPL Associates

    lead OTHER

Principal Investigators

  • Jerome J Schentag, Pharm.D. · State University of NY at Buffalo

  • Joseph Paladino, Pharm.D. · State University of NY at Buffalo

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Completion
2006-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00245440 on ClinicalTrials.gov